Impact of current and scaled-up levels of hepatitis C prevention and treatment interventions for people who inject drugs in three UK settings - what is required to achieve the WHO's HCV elimination targets?

Z. WARD ; L. PLATT ; S. SWEENEY ; V. D. HOPE ; L. MAHER ; S. HUTCHINSON ; N. PALMATEER ; J. SMITH ; N. CRAINE ; A. TAYLOR ; N. MARTIN ; R. AYRES ; J. DILLON ; M. HICKMAN ; P. VICKERMAN | 2018
Dans Addiction (Vol.113, n°9, September 2018) Article : Périodique

Aims: To estimate the impact of existing high-coverage needle and syringe provision (HCNSP, defined as obtaining more than one sterile needle and syringe per injection reported) and opioid substitution therapy (OST) on hepatitis C virus (HCV) tr[...]

Plus d'info

Ajouter à la sélection

Model projections on the impact of HCV treatment in the prevention of HCV transmission among people who inject drugs in Europe

H. FRASER ; N. K. MARTIN ; H. BRUMMER-KORVENKONTIO ; P. CARRIERI ; O. DALGARD ; J. DILLON ; D. GOLDBERG ; S. HUTCHINSON ; M. JAUFFRET-ROUSTIDE ; M. KABERG ; A. A. MATSER ; M. MATICIC ; H. MIDGARD ; V. MRAVCIK ; A. OVREHUS ; M. PRINS ; J. REIMER ; G. ROBAEYS ; B. SCHULTE ; D. K. VAN SANTEN ; R. ZIMMERMANN ; P. VICKERMAN ; M. HICKMAN | 2018
Dans Journal of Hepatology (Vol.68, n°3, March 2018) Article : Périodique

BACKGROUND & AIMS: Prevention of hepatitis C virus (HCV) transmission among people who inject drugs (PWID) is critical for eliminating HCV in Europe. We estimated the impact of current and scaled-up HCV treatment with and without scaling up opio[...]

Plus d'info

Ajouter à la sélection

Lien externe